Lista de obras -

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis

artículo científico publicado en 2012

113. Accuracy of the NHSN Central Line-Associated Bloodstream Infection (CLABSI) Definition

1196. Is the Weekend Staff Really to Blame? Challenges in Isolation Compliance at an Academic Tertiary Care Center

1623. Implementation of Electronic Readmission Alert for Discharged Patients Reduces Risk of Secondary Measles Exposure Events

artículo científico publicado en 2019

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study

1916. Diagnostic Stewardship in Infectious Diseases Molecular Viral Testing: A Pilot Project

2045. Pitfalls in the Use of MALDI TOF Mass Spectrometry for the Identification of Problematic Yeast Isolates from a Historical Collection

2118. Antifungal Susceptibility Testing of Clinical Isolates of Aspergillus in Mexico

artículo científico publicado en 2019

369. Using Hybrid Models and Blockchain Technology as a Means to Develop a Novel Propensity Score for Candidemia and Invasive Candidiasis

40 years of medical mycology at JAC.

artículo científico publicado en 2016

705. Four Superbugs Isolated From a Single Patient in the United States: E. coli (EC) and K. pneumoniae (KP) Harboring NDM-5, P. aeruginosa (PA) Harboring NDM-1 and Candida auris

824An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis.

artículo científico publicado en 2014

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

artículo científico publicado en 2017

A Risk Score for Fluconazole Failure among Patients with Candidemia

artículo científico publicado en 2017

A sentinel COVID‐19 case in Houston, Texas: Informing frontline emergency department screening and preparedness

artículo científico publicado en 2020

A web-based endpoint adjudication system for interim analyses in clinical trials

artículo científico publicado en 2009

Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels

artículo científico publicado en 2009

Amphotericin B: time for a new "gold standard".

artículo científico publicado en 2003

An insight into the antifungal pipeline: selected new molecules and beyond.

artículo científico publicado en 2010

Antifungal Susceptibility Testing: Current Approaches

artículo científico publicado en 2020

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

artículo científico publicado en 2003

Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.

artículo científico publicado en 2004

Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico

artículo científico publicado en 2019

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

artículo científico publicado en 2004

Candida auris: what have we learned so far?

artículo científico publicado en 2019

Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis

artículo científico

Changes in Prevalence of Health Care-Associated Infections

artículo científico publicado en 2019

Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Meningitis

artículo científico publicado en 2016

Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations

artículo científico publicado en 2017

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

artículo científico publicado en 2015

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

artículo científico publicado en 2011

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

artículo científico publicado en 2009

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?

artículo científico publicado en 2011

Combination antifungal therapy

scientific article published on 01 March 2004

Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).

artículo científico publicado en 2016

Contemporary Epidemiology of Catheter-Associated Urinary Tract Infections (CAUTIs) in a Tertiary Care Center: Is Foley Re-Insertion a Novel Risk Factor?

artículo científico publicado en 2017

Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center

artículo científico publicado en 2006

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium

artículo científico publicado en 2020

Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole

artículo científico publicado en 2003

Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.

artículo científico publicado en 2006

Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis

artículo científico publicado en 2012

Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit

artículo científico publicado en 2005

Current options in antifungal pharmacotherapy.

artículo científico publicado en 2008

Deeply invasive candidiasis

artículo científico publicado en 2002

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

artículo científico publicado en 2020

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

artículo científico publicado en 2008

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT1): A Prospective, Multicenter Study of the T2Candida Panel.

artículo científico publicado en 2017

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

artículo científico publicado en 2018

Differences in beta-glucan levels in culture supernatants of a variety of fungi

artículo científico publicado en 2006

Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin

artículo científico publicado en 2003

Drugs in Clinical Development for Fungal Infections

artículo científico publicado en 2017

Drunk Without Drinking: A Case of Auto-Brewery Syndrome

artículo científico publicado en 2019

Early antifungal intervention strategies in ICU patients

artículo científico publicado en 2010

Early treatment of candidemia in adults: a review

artículo científico publicado en 2010

Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida ⬇️

artículo científico publicado el 13 de marzo de 2013

Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro

artículo científico publicado en 2002

Effects of serum on in vitro susceptibility testing of echinocandins

artículo científico publicado en 2007

Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals

article

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

artículo científico publicado en 2016

Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in the United States

artículo científico publicado en 2019

Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation

artículo científico publicado en 2005

Fungal Infections

artículo científico publicado en 2016

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity

scientific article published on 14 August 2020

Hurricane-associated mold exposures among patients at risk for invasive mold infections after Hurricane Harvey - Houston, Texas, 2017

artículo científico publicado en 2019

Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19

artículo científico publicado en 2020

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis

artículo científico publicado en 2017

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

artículo científico publicado en 2011

In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results

artículo científico publicado en 2002

In vitro activity of anidulafungin against selected clinically important mold isolates

scientific article published on May 2004

In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates

artículo científico publicado en 2002

In vitro antifungal susceptibilities of Trichosporon species.

artículo científico publicado en 2002

In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.

artículo científico publicado en 2005

Infections of cardiac implantable electronic devices: a retrospective multicenter observational study

artículo científico publicado en 2012

Integration of aeromedicine in the response to the COVID-19 pandemic

scientific article published on 04 June 2020

Intensive care medicine research agenda on invasive fungal infection in critically ill patients

artículo científico publicado en 2017

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species

artículo científico publicado en 2004

Invasive Candidiasis

artículo científico publicado en 2020

Invasive Fungal Infections in the Intensive Care Unit

artículo científico publicado en 2017

Invasive Mycoses: Diagnostic Challenges ⬇️

artículo científico publicado el 1 de enero de 2012

Invasive candidiasis

Invasive candidiasis in immunocompromised hospitalized patients.

artículo científico publicado en 2005

Invasive candidiasis in the intensive care unit

artículo científico publicado en 2006

Invasive candidiasis in the intensive care unit

artículo científico publicado en 2010

Invasive mycoses: evolving challenges and opportunities in antifungal therapy (multimedia activity)

artículo científico publicado en 2011

Isavuconazole Treatment of Cryptococcosis and Dimorphic Mycoses

scientific article published on 11 May 2016

Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species

artículo científico publicado en 2018

Isavuconazole for treatment of rare invasive fungal diseases

artículo científico publicado en 2018

Isavuconazole treatment for mucormycosis: a single-arm open-label trial and case-control analysis.

artículo científico publicado en 2016

Isavuconazole treatment for rare fungal diseases and for invasive aspergillosis in patients with renal impairment: Challenges and lessons of the VITAL trial.

artículo científico publicado en 2018

Isavuconazole versus Caspofungin in the Treatment of Candidemia and Other Invasive Candida Infections: The ACTIVE Trial

artículo científico publicado en 2019

Isavuconazole: Mechanism of Action, Clinical Efficacy, and Resistance

artículo científico publicado en 2020

Issues in the design and interpretation of antifungal drug trials in the critically ill.

artículo científico publicado en 2009

Lack of correlation of 24- vs. 48-h itraconazole minimum inhibitory concentrations with microbiological and survival outcomes in a guinea pig model of disseminated candidiasis.

artículo científico publicado en 2009

MSG-01: A Randomized, Double-Blind, Placebo-Controlled Trial of Caspofungin Prophylaxis Followed by Preemptive Therapy for Invasive Candidiasis in High-Risk Adults in the Critical Care Setting

scientific article published on 18 February 2014

Measles or Not Measles? That Is the Question!

artículo científico publicado en 2020

Medical order formatting in the era of patient safety

scientific article published on 01 March 2004

Micafungin versus caspofungin for treatment of candidemia and other forms of invasive candidiasis

artículo científico publicado en 2007

Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial

artículo científico publicado en 2007

Mind the Gap: The Hospital Breakroom

scientific article published on 17 June 2020

Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans

artículo científico publicado en 2005

Multilaboratory testing of antifungal combinations against a quality control isolate of Candida krusei

artículo científico publicado en 2008

Multilaboratory testing of two-drug combinations of antifungals against Candida albicans, Candida glabrata, and Candida parapsilosis ⬇️

artículo científico publicado en 2011

New approaches to the risk of Candida in the intensive care unit ⬇️

artículo científico publicado el 1 de diciembre de 2003

Novel approaches to antifungal prophylaxis

artículo científico publicado en 2004

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies

artículo científico publicado en 2006

Outbreak Response and Incident Management: SHEA Guidance and Resources for Healthcare Epidemiologists in United States Acute-Care Hospitals

artículo científico publicado en 2017

Outpatient Infection Prevention: A Practical Primer

artículo científico publicado en 2018

Peritonitis due to Aspergillus and zygomycetes in patients undergoing peritoneal dialysis: report of 2 cases and review of the literature.

artículo científico publicado en 2003

Pharmacoeconomics of antifungal pharmacotherapy--challenges and future directions.

artículo científico publicado en 2005

Pharmacokinetic evaluation of single-dose intravenous daptomycin in patients with thermal burn injury

artículo científico publicado en 2008

Pharmacokinetics of intravenous itraconazole in stable hemodialysis patients.

artículo científico publicado en 2004

Pneumococcal epidemiology among us adults hospitalized for community-acquired pneumonia

scientific article published on 06 May 2019

Point-Counterpoint: Should Serum β-d-Glucan Testing Be Used for the Diagnosis of Pneumocystis jirovecii Pneumonia?

artículo científico publicado en 2019

Post-exposure prophylaxis with isavuconazole after occupational exposure to

Povidone-iodine solution as SARS-CoV-2 prophylaxis for procedures of the upper aerodigestive tract a theoretical framework

artículo científico publicado en 2020

Prevalence and risk factors of methicillin-resistant Staphylococcus aureus colonization among critically ill hospitalized patients in a tertiary care center in Houston, Texas: an active surveillance pilot project

artículo científico publicado en 2010

Progressive Dispersion of Azole Resistance in Aspergillus fumigatus: Fatal Invasive Aspergillosis in a Patient with Acute Myeloid Leukemia Infected with an A. fumigatus Strain with a cyp51A TR46 Y121F M172I T289A Allele ⬇️

artículo científico publicado en 2017

Prophylaxis for invasive candidiasis in the intensive care unit: is it time?

artículo científico publicado en 2005

Prophylaxis or preemptive therapy of invasive candidiasis in the intensive care unit?

artículo científico publicado en 2004

Prospective survey of (1→3)-beta-D-glucan and its relationship to invasive candidiasis in the surgical intensive care unit setting

artículo científico publicado en 2010

Prosthetic Joint Infection Due to Histoplasma capsulatum Complicating a Total Knee Arthroplasty

artículo científico publicado en 2017

Quality Control Guidelines for Amphotericin B, Itraconazole, Posaconazole, and Voriconazole Disk Diffusion Susceptibility Tests with Nonsupplemented Mueller-Hinton Agar (CLSI M51-A Document) for Nondermatophyte Filamentous Fungi ⬇️

artículo científico publicado el 4 de mayo de 2011

Rationale for reading fluconazole MICs at 24 hours rather than 48 hours when testing Candida spp. by the CLSI M27-A2 standard method

artículo científico publicado en 2008

Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry

artículo científico publicado en 2023

Reply to "Why should we monitor (1-3)-β-D-glucan levels during invasive candidiasis? Just ask your ophthalmologist!".

artículo científico publicado en 2013

Reply to Bauer and Goff

artículo científico publicado en 2015

Reply to Chow and Hurley

artículo científico publicado en 2012

Reprocessing N95s with Hydrogen peroxide vaporization: A robust system from collection to dispensing

artículo científico publicado en 2020

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium

scientific article published on 05 December 2019

Rezafungin versus Caspofungin in a Phase 2, Randomized, Double-Blind Study for the Treatment of Candidemia and Invasive Candidiasis- The STRIVE Trial

scientific article published on 21 September 2020

Risk factors for hyperglycemia in hospitalized adults receiving gatifloxacin: a retrospective, nested case-controlled analysis

artículo científico publicado en 2008

Rules for identifying patients at increased risk for candidal infections in the surgical intensive care unit: approach to developing practical criteria for systematic use in antifungal prophylaxis trials

scientific article published on 01 May 2005

Screening Donors for COVID-19 Convalescent Plasma

artículo científico publicado en 2020

Seroprevalence of Strongyloides stercoralis and Evaluation of Universal Screening in Kidney Transplant Candidates: A Single-Center Experience in Houston (2012-2017)

artículo científico publicado en 2019

Simultaneous Infection with Enterobacteriaceae and Pseudomonas aeruginosa Harboring Multiple Carbapenemases in a Returning Traveler Colonized with Candida auris

scientific article published on 27 January 2020

Successful implementation of the CDC recommendations during the care of two patients with Candida auris in in-patient rehabilitation and intensive care settings

scientific article published on 20 August 2020

Successful use of amphotericin B lipid complex in the treatment of cryptococcosis

artículo científico publicado en 2005

Surveillance of Candida spp bloodstream infections: epidemiological trends and risk factors of death in two Mexican tertiary care hospitals

artículo científico publicado en 2014

Syscan3, a kit for detection of anti-Candida antibodies for diagnosis of invasive candidiasis.

artículo científico publicado en 2005

Systemic antifungal therapy in patients without documented invasive fungal infection: a peek into the world of empirical antifungal therapy*

artículo científico publicado en 2012

T2 magnetic resonance assay for the rapid diagnosis of candidemia in whole blood: a clinical trial

artículo científico publicado en 2015

The Role of In Vitro Susceptibility Testing in the Management of Candida and Aspergillus

artículo científico publicado en 2017

Therapy of common superficial fungal infections

artículo científico publicado en 2004

Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris

artículo científico publicado en 2017

Tigecycline : a critical safety review

artículo científico publicado en 2015

Treatment of candidemia and invasive candidiasis in the intensive care unit: post hoc analysis of a randomized, controlled trial comparing micafungin and liposomal amphotericin B.

artículo científico publicado en 2009

Ventilator-associated pneumonia: a review

artículo científico publicado en 2012

What's new in the clinical and diagnostic management of invasive candidiasis in critically ill patients

artículo científico

Lista de obras de

(1,3)-β-D-glucan as a prognostic marker of treatment response in invasive candidiasis

113. Accuracy of the NHSN Central Line-Associated Bloodstream Infection (CLABSI) Definition

1196. Is the Weekend Staff Really to Blame? Challenges in Isolation Compliance at an Academic Tertiary Care Center

1623. Implementation of Electronic Readmission Alert for Discharged Patients Reduces Risk of Secondary Measles Exposure Events

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study

1916. Diagnostic Stewardship in Infectious Diseases Molecular Viral Testing: A Pilot Project

2045. Pitfalls in the Use of MALDI TOF Mass Spectrometry for the Identification of Problematic Yeast Isolates from a Historical Collection

2118. Antifungal Susceptibility Testing of Clinical Isolates of Aspergillus in Mexico

369. Using Hybrid Models and Blockchain Technology as a Means to Develop a Novel Propensity Score for Candidemia and Invasive Candidiasis

40 years of medical mycology at JAC.

705. Four Superbugs Isolated From a Single Patient in the United States: E. coli (EC) and K. pneumoniae (KP) Harboring NDM-5, P. aeruginosa (PA) Harboring NDM-1 and Candida auris

824An Open-Label Phase 3 Study of Isavuconazole (VITAL): Focus on Mucormycosis.

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

A Risk Score for Fluconazole Failure among Patients with Candidemia

A sentinel COVID‐19 case in Houston, Texas: Informing frontline emergency department screening and preparedness

A web-based endpoint adjudication system for interim analyses in clinical trials

Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1,3)-beta-D-glucan levels

Amphotericin B: time for a new "gold standard".

An insight into the antifungal pipeline: selected new molecules and beyond.

Antifungal Susceptibility Testing: Current Approaches

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private, university-affiliated teaching hospital: an 8-year-experience: 1995-2002.

Azole resistance and cyp51A mutation screening in Aspergillus fumigatus in Mexico

Beta-D-glucan as a diagnostic adjunct for invasive fungal infections: validation, cutoff development, and performance in patients with acute myelogenous leukemia and myelodysplastic syndrome

Candida auris: what have we learned so far?

Cerebrospinal fluid Coccidioides antigen testing in the diagnosis and management of central nervous system coccidioidomycosis

Changes in Prevalence of Health Care-Associated Infections

Clinical Characteristics and Predictors of Adverse Outcome in Adult and Pediatric Patients With Healthcare-Associated Ventriculitis and Meningitis

Clinical Outcomes in Patients With Gram-Negative Infections Treated With Optimized Dosing Cefepime Over Various Minimum Inhibitory Concentrations

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Clinical breakpoints for voriconazole and Candida spp. revisited: review of microbiologic, molecular, pharmacodynamic, and clinical data as they pertain to the development of species-specific interpretive criteria

Clinical practice guidelines for the management of candidiasis: 2009 update by the Infectious Diseases Society of America.

Clinical prediction rules for invasive candidiasis in the ICU: ready for prime time?

Combination antifungal therapy

Comparative effectiveness of echinocandins versus fluconazole therapy for the treatment of adult candidaemia due to Candida parapsilosis: a retrospective observational cohort study of the Mycoses Study Group (MSG-12).

Contemporary Epidemiology of Catheter-Associated Urinary Tract Infections (CAUTIs) in a Tertiary Care Center: Is Foley Re-Insertion a Novel Risk Factor?

Contemporary treatment and outcomes of zygomycosis in a non-oncologic tertiary care center

Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education and Research Consortium

Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole

Correlation between microdilution, E-test, and disk diffusion methods for antifungal susceptibility testing of posaconazole against Candida spp.

Correlation of clinical outcomes with β-glucan levels in patients with invasive candidiasis

Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit

Current options in antifungal pharmacotherapy.

Deeply invasive candidiasis

Defining and managing COVID-19-associated pulmonary aspergillosis: the 2020 ECMM/ISHAM consensus criteria for research and clinical guidance

Defining responses to therapy and study outcomes in clinical trials of invasive fungal diseases: Mycoses Study Group and European Organization for Research and Treatment of Cancer consensus criteria

Detecting Infections Rapidly and Easily for Candidemia Trial (DIRECT1): A Prospective, Multicenter Study of the T2Candida Panel.

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

Differences in beta-glucan levels in culture supernatants of a variety of fungi

Disk diffusion-based methods for determining Candida parapsilosis susceptibility to anidulafungin

Drugs in Clinical Development for Fungal Infections

Drunk Without Drinking: A Case of Auto-Brewery Syndrome

Early antifungal intervention strategies in ICU patients

Early treatment of candidemia in adults: a review

Editorial Commentary: Candida glabrata and FKS Mutations: Witnessing the Emergence of the True Multidrug-Resistant Candida ⬇️

Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitro

Effects of serum on in vitro susceptibility testing of echinocandins

Evaluation of BacT/Alert FA Blood Culture Bottles and T2Candida Assay for Detection of Candida in the Presence of Antifungals

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Extensively Drug-Resistant Pseudomonas aeruginosa ST309 Harboring Tandem Guiana Extended Spectrum β-Lactamase Enzymes: A Newly Emerging Threat in the United States

Fatal amphotericin B overdose due to administration of nonlipid formulation instead of lipid formulation

Fungal Infections

Heterogeneous antibodies against SARS-CoV-2 spike receptor binding domain and nucleocapsid with implications on COVID-19 immunity

Hurricane-associated mold exposures among patients at risk for invasive mold infections after Hurricane Harvey - Houston, Texas, 2017

Identification of IgG antibody response to SARS-CoV-2 spike protein and its receptor binding domain does not predict rapid recovery from COVID-19

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis

Improvement of a clinical prediction rule for clinical trials on prophylaxis for invasive candidiasis in the intensive care unit

In vitro activities of investigational triazoles against Fusarium species: effects of inoculum size and incubation time on broth microdilution susceptibility test results

In vitro activity of anidulafungin against selected clinically important mold isolates

In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolates

In vitro antifungal susceptibilities of Trichosporon species.

In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp.

Infections of cardiac implantable electronic devices: a retrospective multicenter observational study

Integration of aeromedicine in the response to the COVID-19 pandemic

Intensive care medicine research agenda on invasive fungal infection in critically ill patients

Interlaboratory comparison of results of susceptibility testing with caspofungin against Candida and Aspergillus species

Invasive Candidiasis

Invasive Fungal Infections in the Intensive Care Unit

Invasive Mycoses: Diagnostic Challenges ⬇️